Rebecca Wendt
Family Medicine · Colorado Springs, CONPI 1407219108
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 54 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 22 manufacturers, the largest accounting for just 13.4% — the pattern of someone who eats at a lot of different presentations.
Across 54 payments — averaging $21.01 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$152
- Boehringer Ingelheim$147
- AbbVie$145
- Novo Nordisk$130
- Genentech USA, Inc.$104
- Inspire Medical Systems, Inc.$62
- plus $395 from 16 others
What the payments were for
- Food & beverage$1,135100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 8 | $152 |
| Boehringer Ingelheim | 6 | $147 |
| AbbVie | 7 | $145 |
| Novo Nordisk | 7 | $130 |
| Genentech USA, Inc. | 2 | $104 |
| Inspire Medical Systems, Inc. | 1 | $62 |
| Exact Sciences | 4 | $57 |
| Bayer | 2 | $37 |
| Merck | 2 | $31 |
| Lilly USA, LLC | 2 | $29 |
| Sanofi | 1 | $27 |
| Esperion Therapeutics, Inc. | 2 | $26 |
| GSK | 1 | $26 |
| Hologic Sales And Service, LLC | 1 | $25 |
| Astellas Pharma US Inc | 1 | $22 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $21 |
| Cranial Technologies, Inc | 1 | $19 |
| Lifescan, Inc. | 1 | $17 |
| Axsome Therapeutics, Inc. | 1 | $16 |
| Idorsia Pharmaceuticals US Inc | 1 | $15 |
| Pfizer | 1 | $14 |
| Sunovion Pharmaceuticals Inc. | 1 | $13 |
How this compares
$1,135 in reported general payments places this provider in the 80th percentile of 2,079 family medicine providers in Colorado.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Atorvastatin Calcium | 112 | $1,066 |
| Gabapentin | 16 | $825 |
| Omeprazole | 32 | $568 |
| Levothyroxine Sodium | 57 | $538 |
| Duloxetine Hcl | 12 | $461 |
| Ipratropium Bromide | 12 | $412 |
| Rosuvastatin Calcium | 60 | $401 |
| Amlodipine Besylate | 37 | $272 |
| Lisinopril | 38 | $266 |
| Sertraline Hcl | 23 | $235 |
| Losartan Potassium | 39 | $226 |
| Buspirone Hcl | 16 | $207 |
| Fluoxetine Hcl | 20 | $174 |
| Simvastatin | 23 | $165 |
| Hydrochlorothiazide | 26 | $146 |
Paid to pharmacies, not to this prescriber.
Other family medicine in Colorado Springs
- Matthew YoungColorado Springs$270K
- Lawrence AndrewsColorado Springs$102K
- Elizabeth EricksonColorado Springs$31K
- Daniel RohwederColorado Springs$21K
- Gary TarshisColorado Springs$10K
- Jeremy BrownColorado Springs$8K
- Ethan LazarusDenver$688K
- Michael de NardisLarkspur$335K
- Mark DeutchmanDenver$258K
- Kari UusinarkausWoodland Park$254K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.